Update on education and technology

Abstract

The incorporation of continuous glucose monitoring (CGM) and automated insulin delivery (AID) systems has transformed the management of children and adolescents with type 1 diabetes (T1D), enabling a more precise and individualized approach to care.

Evidence demonstrates that these technologies not only improve glycemic outcomes but also enhance quality of life and reduce treatment burden, defined as the physical, cognitive, and emotional demands associated with the daily management of diabetes. These benefits have a positive impact on the well-being of both children and their caregivers.

However, the clinical benefits of these technologies depend on their integration with structured, ongoing, and person-centered Diabetes Self-Management Education and Support (DSMES) programs tailored to children, adolescents, and their caregivers. DSMES is an essential component of comprehensive diabetes care, promoting the acquisition of the knowledge, competencies, and skills required to interpret technology-generated data, make informed therapeutic decisions, and develop safe and effective self-management practices.

DSMES programs that incorporate the systematic review of CGM data together with regular feedback from the healthcare team have been associated with reductions in glycated hemoglobin (HbA1c), increased time in range (TIR), and improved treatment adherence.

Current evidence supports DSMES as an indispensable component of T1D care in the era of diabetes technologies. Its integration with therapeutic innovations facilitates the appropriate use of diabetes devices and contributes to improved metabolic outcomes and enhanced quality of life for children, adolescents, and their caregivers.

In Argentina, the major challenge is to expand equitable access to diabetes technologies while strengthening educational models that are tailored to the needs of each individual.